Skip to main navigation Skip to search Skip to main content

The sodium/glucose cotransporter 2 inhibitor empagliflozin is a pharmacological chaperone of cardiac Nav1.5 channels

  • Jakob Sauer
  • , Jessica Marksteiner
  • , Martin Hohenegger
  • , Hannes Todt
  • , Helmut Kubista
  • , Christopher Dostal
  • , Attila Kiss
  • , Bruno Podesser
  • , Isabella Salzer
  • , Xaver König
  • , Anna Weinzinger
  • , Karlheinz Hilber (Corresponding author)
  • , Oliver Kudlacek

Publications: Contribution to journalArticlePeer Reviewed

Original languageEnglish
JournalAmerican Journal of Physiology. Heart and Circulatory Physiology
Publication statusPublished - 2025

Austrian Fields of Science 2012

  • 301206 Pharmacology

Cite this